Naiya Patel
Allergy & Immunology · Arlington, TXNPI 1740711928
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.8% of the total across 381 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 34 manufacturers, the largest accounting for just 17.1% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $2,826, more than ten times the $125 reported in 2021.
Across 381 payments — averaging $22.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Regeneron Healthcare Solutions, Inc.$1K
- GSK$1K
- AstraZeneca$961
- Sanofi$630
- Novartis$509
- Takeda Pharmaceuticals U.S.A., Inc.$437
- plus $3K from 28 others
What the payments were for
- Food & beverage$8,26398%
- Education$1842%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 44 | $1,444 |
| GSK | 60 | $1,040 |
| AstraZeneca | 47 | $961 |
| Sanofi | 25 | $630 |
| Novartis | 22 | $509 |
| Takeda Pharmaceuticals U.S.A., Inc. | 23 | $437 |
| CSL Behring | 17 | $404 |
| Grifols USA, LLC | 14 | $334 |
| Kaleo, Inc. | 21 | $318 |
| Pfizer | 12 | $273 |
| Blueprint Medicines Corporation | 7 | $273 |
| Genentech USA, Inc. | 10 | $222 |
| Biocryst US Sales Co., LLC | 10 | $201 |
| Amgen | 9 | $152 |
| Pharming Healthcare, Inc. | 6 | $140 |
| ARS Pharmaceuticals Operations, Inc. | 6 | $134 |
| Optinose US, Inc. | 6 | $121 |
| LEO Pharma Inc. | 6 | $118 |
| Arcutis Biotherapeutics, Inc. | 5 | $95 |
| Sanofi-aventis U.S. LLC | 1 | $95 |
| Organon | 7 | $86 |
| Teva Pharmaceuticals USA, Inc. | 4 | $76 |
| Alk-abello, Inc | 3 | $66 |
| Octapharma USA, Inc. | 2 | $53 |
| Incyte Corporation | 2 | $47 |
| Azurity Pharmaceuticals, Inc. | 2 | $43 |
| Hikma Pharmaceuticals USA | 2 | $34 |
| Covis Pharma GmbH | 2 | $32 |
| Lilly USA, LLC | 1 | $23 |
| Merck | 1 | $21 |
| AbbVie | 1 | $17 |
| Phadia US Inc. | 1 | $17 |
| Genentech, Inc. | 1 | $17 |
| Galderma Laboratories, L.p. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,447 in reported general payments places this provider in the 55th percentile of 336 allergy & immunology providers in Texas.
Other allergy & immunology in Arlington
- Neil SinghaniaArlington$26K
- Joseph DiazSan Antonio$1.1M
- Richard WassermanDallas$452K
- Matthew FeldmanDallas$410K
- Lukena KarkhanisSan Antonio$377K
- Paul VigoAustin$304K
- Neha ReshamwalaAustin$303K
- Lara GrossDallas$171K
- Bobby LanierBenbrook$149K
- Juan ZambranoHouston$146K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.